Fountainheadinvesting

Categories
Industrials

In-Depth Analysis of Archer Aviation (ACHR): A Speculative Play in eVTOL with R&D Challenges and Competitive Landscape

Archer Aviation (ACHR)

Pre-Revenue, majority spend in R&D.

Lot of dilution (likely to continue at double digits each year if not more) due to equity funding for R&D, still has about $325 Mn in net cash a year worth of expenses.

Positives include a $140Mn DoD contract, plus scope to expand in India and the middle east. United Airlines even though it is a large strategic partnership, it is non-binding – so difficult to predict what might transpire.

Also, an ongoing effort to reduce expenses to stretch cash a couple of years.

Biggest negative/challenge is getting certification and there is a milestone for 2024 testing so let’s see how that goes.

Interestingly, if eVTOL (Vertical take-off of aircraft) gets a mandate it would be a massive market.

Closest competitor among many is Joby is at a similar position developmentally and operationally, their ongoing testing program has a likely 6 to 12-month lead over Archer Aviation with successful flights in NYC, but Archer should be able to close that.

JOBY’s key supplier relationship with Toyota is a big plus.

ACHR’s primary focus is on manufacturing and selling eVTOL aircraft, while JOBY’s business model is more full stack, creation and operational management, thus Joby’s valuation is stronger. 

Bottom line – speculative volatile play for sure + definite dilution, but if successful could be huge. I’m sure your position would be small relative to the portfolio, and as long as you can deal with the volatility nothing wrong in accumulating but do keep an eye out on JOBY, the Toyota angle looks interesting.

Categories
Technology

Rivian (RIVN) Analysis: $11.30 – Avoid Until Signs of Stability Emerge

The situation is even worse than expected with only 57K vehicle production for 2024 – no growth, production cuts, workforce cuts, hardly breaking even at gross levels.

Here is the company’s outlook, which inspired no confidence.

“For 2024, we expect our total deliveries to be derived from our existing order bank as well as new orders generated during the year. Our full year targets rely on an improvement in order rate driven by our planned go-to-market strategies. The conversion of our existing order bank to sales can be impacted by several factors including delivery timing, location of order, monthly payments, and customer readiness. Our order bank has notably reduced over time as deliveries more than doubled in 2023 versus 2022, and we have incurred cancellations due to macro and customer factors.”

Conference call, filled with underwhelming guidance and management’s approach to addressing the current challenges, the business model was questioned – do they even need a new plant? The sheer magnitude of the projected shortfall and the apparent lack of more decisive action is also baffling.

There is a lot of risk in the current market environment, particularly given the required $5 billion investment in conjunction with the new Georgia plant to facilitate the production of Rivian’s mass-market R2 vehicles.

Categories
Technology

Tesla: Why I’m Buying on Declines Between $160 and $190 Despite Margin Pressures and Competition

Tesla (TSLA) Buy on declines $160-190

I own Tesla and have been holding it patiently.

Tesla has operating margin compression from 16% to 9% and there is no way they can continue to grow without sacrificing margins, otherwise, they get saddled with excess production capacity and inventory – which are equally bad problems. There’s far more competition, Chinese demand is lower, and suddenly you’re looking at it as an auto company with all its associated auto industry problems and a lower multiple.

I guess the main question is how much of it is already in the price – Tesla has dropped 33% from its 52 week high of $300, and rebounding from $182.

Earnings – Priced at 59x with 24% growth, about 10% overpriced.

Sales – 5.5X sales with 18% growth – also overpriced, because it doesn’t have the tech operating margins anymore and even in the best case will go to 15-16% of sales.

That said – it is far ahead in innovation and scale and very likely remain so in spite of the Musk personality and the various chemicals that go with it.